V Eskandari1, A A Amirzargar1, M J Mahmoudi2, Z Rahnemoon3, F Rahmani4,5, S Sadati1, Z Rahmati1, F Gorzin1, M Hedayat6,7, N Rezaei8,9,10. 1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 2. Department of Cardiology, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran. 3. Cardiac Heart Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 4. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. 6. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. 7. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA, USA. 8. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir. 9. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir. 10. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.
Abstract
BACKGROUND: Evidence shows that proinflammatory cytokines are important determinants of assessment of severity and prognosis of chronic heart failure (CHF). AIMS: We investigated whether peripheral expression of the proinflammmatory factors, TNF-α and IL-6 can predict variable of clinical assessment of patients with CHF. METHODS: In this report, we used real-time PCR assay to compare relative gene expression of TNFα and IL-6 in PBMC from CHF patients with various heart diseases (n = 42, EF < 45%, NYHA I to IV) and matched healthy control subjects (n = 42).We also determined the TNFα and IL-6 concentrations of cell culture supernatant of PBMCs with ELISA. RESULTS: There was a significant negative correlation between gene expression of TNFα and LVEF(r = 0.4, p < 0.05). Patients with CHF had increased gene expression of TNFα and IL-6 in PBMCs (p < 0.05). They also had elevated the supernatant levels of these cytokines in cultured PBMCs (p < 0.001). Levels of TNFα and IL-6 were increased in ischemic heart disease compared to non-ischemic heart disease. There was a positive correlation between TNFα and IL-6 levels in CHF patients and severity of CHF in patients. Levels of these cytokines were higher in patients with NYHA III-IV than in NYHA I-II and normal subjects. CONCLUSIONS: Results of this study indicate that peripheral expression of proinflammatory cytokines, TNF-α and IL-6, is important indicators of severity and prognosis in patients with chronic heart disease.
BACKGROUND: Evidence shows that proinflammatory cytokines are important determinants of assessment of severity and prognosis of chronic heart failure (CHF). AIMS: We investigated whether peripheral expression of the proinflammmatory factors, TNF-α and IL-6 can predict variable of clinical assessment of patients with CHF. METHODS: In this report, we used real-time PCR assay to compare relative gene expression of TNFα and IL-6 in PBMC from CHFpatients with various heart diseases (n = 42, EF < 45%, NYHA I to IV) and matched healthy control subjects (n = 42).We also determined the TNFα and IL-6 concentrations of cell culture supernatant of PBMCs with ELISA. RESULTS: There was a significant negative correlation between gene expression of TNFα and LVEF(r = 0.4, p < 0.05). Patients with CHF had increased gene expression of TNFα and IL-6 in PBMCs (p < 0.05). They also had elevated the supernatant levels of these cytokines in cultured PBMCs (p < 0.001). Levels of TNFα and IL-6 were increased in ischemic heart disease compared to non-ischemic heart disease. There was a positive correlation between TNFα and IL-6 levels in CHFpatients and severity of CHF in patients. Levels of these cytokines were higher in patients with NYHA III-IV than in NYHA I-II and normal subjects. CONCLUSIONS: Results of this study indicate that peripheral expression of proinflammatory cytokines, TNF-α and IL-6, is important indicators of severity and prognosis in patients with chronic heart disease.
Authors: P Aukrust; T Ueland; F Müller; A K Andreassen; I Nordøy; H Aas; J Kjekshus; S Simonsen; S S Frøland; L Gullestad Journal: Circulation Date: 1998-03-31 Impact factor: 29.690
Authors: Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming Journal: Circulation Date: 2004-03-15 Impact factor: 29.690
Authors: Jing Wu; Joanna Stefaniak; Christina Hafner; Johannes Peter Schramel; Christoph Kaun; Johann Wojta; Roman Ullrich; Verena Eva Tretter; Klaus Markstaller; Klaus Ulrich Klein Journal: Anesth Analg Date: 2016-02 Impact factor: 5.108
Authors: Maria E R Coste; Carolina N França; Maria Cristina Izar; Daniela Teixeira; Mayari E Ishimura; Ieda Longo-Maugeri; Amanda S Bacchin; Henrique Tria Bianco; Flavio T Moreira; Ibraim Masciarelli Pinto; Gilberto Szarf; Adriano Mendes Caixeta; Otavio Berwanger; Iran Gonçalves; Francisco A H Fonseca Journal: Arq Bras Cardiol Date: 2020-12 Impact factor: 2.000
Authors: Amany H Abdelrahman; Iman I Salama; Somaia I Salama; Dalia M Elmosalami; Mona H Ibrahim; Eman M Hassan; Mark O Dimitry; Zahraa I Aboafya; Mohammad Gouda Mohammad; Mohamed Amin Journal: Future Sci OA Date: 2021-02-04